1Jordan MS, Riley MP. CD4+T cell responses to a self peptide[J].Eur J Immunol,2000,30(1):136-144.
2Pai SY, Truitt ML, Ting CN, et al.Critical roles for transcription factor GATA-3 in thymocyte development cell[J]. Immunity, 2003,19(6):863-875.
3Bruder D, Probst-Kepper M, Westendorf AM, et al. Neuropilin-1:a surface marker of regulatory T cells[J]. Eur J Immunol, 2004,34(3):623-630.
4Miura Y, Thoburn C J, Bright EC,et al. Regulation of OX40 gene expression in graft-versus-host disease[J]. Transplant Proc, 2005, 37(1):57-61.
5Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 +CD25 + regulatory T cells[J]. Nat Immunol,2003,4(4):330-336.
6Viguier M, Lemaitre F, Verola O ,et al. Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells[J].J Immunol, 2004,173(2):1444-1453.
7Pontoux C, Banz A, Papiernik M.Natural CD4 +CD25 + regulatory T cells control the burst of superantigen-induced cytokine production: the role of IL-10[J]. Int Immunol, 2002, 14(2):233-239.
8Shevach EM, McHugh RS, Piccirillo CA, et al. Control of T-cell activation by CD4+ CD25+ suppressor T cells[J]. Immunol Rev, 2001,182:58-67.
9Thornton AM. Activation requirements for the induction of CD4 + CD25+T cell suppressor function[J].Eur J Immunol,2004,34:366-376.
10Sasada T, Kimura M, Yoshida Y,et al. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies :possible involvement of regulatory T cells in disease progression [J].Cancer,2003,98 (5):1089-1099.
5Apostolou I,Von Boehmer H.In vivo instruction of suppressor commitment in native T cells[J].J Exp Med,2004,199(10):1401-1408.
6Van den Hove LE, Van Gool SW, Van Poppel H, et al. Phenotype, cytokine production and cytolytic capacity of fresh ( uncultured ) tumourinfiltrating T lymphocytes in human renal cell carcinoma [ J]. Clin Exp Immunol,1997,109 : 501 - 509.
7Hernberg M,Muhonen T,Turunen JP,et al. The CD4 +/CD8 + ratio as a prognostic factor in patients with metastatic melanoma receiving che- moimmunotherapy [ J ]. J Clin Oncol, 1996,14 : 1690 - 1696.
8Woo EY, Yeh H, Chu CS, et al. Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation [ J ]. J Immunol,2002,168 .. 4272 - 4276.
9Giatromanolaki A, Bates GJ, Koukourakis MI, et al. The presence of tumor- infiltrating FOXP3 + lymphocytes correlates with intra- tumoral angiogenesis in endometrial cancer [ J]. Gynecol Oncol, 2008,110:216-221.
10Somasundaram R, Jacob L, Swoboda R, et al. Inhibition of eytolytic T lymphocyte proliferation by autologous CD4 +/CD25 + regulatory T ceils in a eolorectal carcinoma patient is mediated by transforming growth factor - beta [ J ]. Cancer Res,2002,62 : 5267 - 5272.
